Reaction Biology’s Novel Approach to Oncology Drug Discovery at AACR Showcase

By | April 13, 2022
Reaction Biology, an industry-leading provider of drug discovery services, today announced that twelve abstracts highlighting data from the Company’s oncology drug discovery services platform will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2022, held April 8-13, 2022, in New Orleans, Louisiana.